Filing Details
- Accession Number:
- 0001591986-20-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-22 18:15:47
- Reporting Period:
- 2020-07-21
- Accepted Time:
- 2020-07-22 18:15:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583648 | Pieris Pharmaceuticals Inc. | PIRS | Services-Commercial Physical & Biological Research (8731) | 300784346 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591986 | Aquilo Capital Management, Llc | One Letterman Drive Suite D4900, Building D San Francisco CA 94129 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2020-07-21 | 1,900,000 | $2.95 | 3,675,530 | No | 4 | S | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnotes |
Footnotes
- The reporting persons are Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of investment funds that hold these securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of those funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of Aquilo and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.
Billionaire Hedge Funds
